You have 9 free searches left this month | for more free features.

OPAT

Showing 1 - 25 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa Trial (Ceftolozane/tazobactam)

Not yet recruiting
  • Bronchiectasis
  • +3 more
  • (no location specified)
Sep 6, 2023

Gather Clinical Information From Patients Following Hospital

Recruiting
  • Outpatient Parenteral Antibiotic Therapy
  • OPAT
  • Focus Group
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Jul 6, 2022

Opioid Use Disorder Trial in Saint Louis (OPAT for PWID)

Recruiting
  • Opioid Use Disorder
  • OPAT for PWID
  • Saint Louis, Missouri
    Washington Univeristy
Mar 18, 2022

Implementation of OPAT in Germany Trial in Cologne (Outpatient Parenteral Antibiotic Therapy)

Recruiting
  • Implementation of OPAT in Germany
  • Outpatient Parenteral Antibiotic Therapy
  • Cologne, Germany
    University of Cologne
Oct 5, 2021

Outpatient Parenteral Antimicrobial Therapy (OPAT)

Recruiting
  • Infections
  • Outpatient parenteral antimicrobial therapy
  • Lausanne, Switzerland
    Department of Outpatient Care and Community Medicine, University
Oct 22, 2020

Implementation of OPAT in Germany Trial in Cologne (Outpatient Parenteral Antibiotic Therapy)

Recruiting
  • Implementation of OPAT in Germany
  • Outpatient Parenteral Antibiotic Therapy
  • Cologne, Germany
    University Hospital of Cologne
Nov 3, 2020

Outpatient Trial in Monterrey (Place of treatment)

Recruiting
  • Outpatient
  • Place of treatment
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario José E. Gonzalez
Jan 28, 2023

Endocarditis Infective Trial in Barcelona (Cefaclor, Ciprofloxacin Tablets, Ciprofloxacin Injection)

Not yet recruiting
  • Endocarditis Infective
  • Barcelona, Spain
    Hospital Clinic i Provincial de Barcelona
May 26, 2022

Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection Trial in Morgantown (Amoxicillin,

Not yet recruiting
  • Endovascular Infection
  • +5 more
  • Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid
  • Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem
  • Morgantown, West Virginia
    West Virginia University
Jul 24, 2023

Drug Use, Opioid-use Disorder Trial in Lexington (Buprenorphine and Outpatient Parenteral Antibiotic Therapy, Buprenorphine and

Recruiting
  • Drug Use
  • Opioid-use Disorder
  • Buprenorphine and Outpatient Parenteral Antibiotic Therapy
  • Buprenorphine and standard of care antibiotic treatment
  • Lexington, Kentucky
    University of Kentucky
Nov 7, 2022

Infection Trial in Winston-Salem (Vancomycin CI, Vancomycin II)

Recruiting
  • Infection
  • Vancomycin CI
  • Vancomycin II
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Feb 16, 2022

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
Oct 23, 2022

Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Sepsis Bacterial Trial (PET/CT)

Not yet recruiting
  • Staphylococcus Aureus Bacteremia
  • +6 more
  • PET/CT
  • (no location specified)
Apr 29, 2022

Infection, Bacterial Trial (Isothermal pouch)

Not yet recruiting
  • Infection, Bacterial
  • Isothermal pouch
  • (no location specified)
Aug 22, 2022

Vascular Surgery Admissions inTertiary Care Hospital in

Not yet recruiting
  • Vascular Diseases
  • Surgery
  • (no location specified)
Jun 21, 2022

Endocarditis, Bacterial, Opioid-use Disorder, Buprenorphine Trial in Lexington (Outpatient parenteral antibiotic therapy)

Completed
  • Endocarditis, Bacterial
  • +3 more
  • Outpatient parenteral antibiotic therapy
  • Lexington, Kentucky
    University of Kentucky
Jan 21, 2019

Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Zanubrutinib, Bendamustine and Rituximab
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

Staphylococcus Aureus Bacteremia Trial in Worldwide (Cefazolin, Penicillin, Clindamycin)

Recruiting
  • Staphylococcus Aureus Bacteremia
  • Garran, Australia Capital Territory, Australia
  • +73 more
Feb 23, 2022

Thrombotic Thrombocytopenic Purpura, Acquired Trial in Beijing (Bortezomib Injection)

Not yet recruiting
  • Thrombotic Thrombocytopenic Purpura, Acquired
  • Bortezomib Injection
  • Beijing, (Select), China
    Peking Union Medical College Hospital
Nov 22, 2021

Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

Recruiting
  • Atrial Fibrillation
  • +4 more
  • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
  • New Hyde Park, New York
    Northwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) Trial in Basel (FLU or CZO as continuous infusion, standard FLU

Not yet recruiting
  • Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
  • FLU or CZO as continuous infusion
  • standard FLU or CZO intermittent bolus administration
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Dec 14, 2022

Autoimmune Hemolytic Anemia, Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia Trial in Beijing (combination of a

Recruiting
  • Autoimmune Hemolytic Anemia
  • Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
  • combination of a single dose anti-CD20 antibody and bortezomib
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 12, 2021

Beta-lactam Pharmacokinetics in Secondary Care

Completed
  • Pharmacokinetics
  • +2 more
  • Beta-lactam antibiotic
  • London, United Kingdom
    Hammersmith Hospital
Aug 4, 2021

Gram-Positive Bacterial Infections, Gram-Positive Bacteraemia, Substance Use Disorders Trial in Aurora (Dalbavancin)

Enrolling by invitation
  • Gram-Positive Bacterial Infections
  • +3 more
  • Aurora, Colorado
    University of Colorado Hospital
May 4, 2021